Chinese drugmaker says its COVID-19 vaccine is almost 80% effective
By (0)
Unlike messenger RNA vaccines from Pfizer-BioNTech and Moderna, Sinopharm s use an inactivated virus as the platform to produce an antibody response. Photo by Debbie Hill/UPI | License Photo
Dec. 30 (UPI) Chinese drugmaker Sinopharm said Wednesday that interim clinical trial results have shown that one of two COVID-19 vaccines it s testing is almost 80% effective in blocking the coronavirus.
The results were announced and released by the Beijing Institute of Biological Products, a subsidiary of state-owned Sinopharm.
Advertisement
Company officials did not provide additional data, but said the vaccine has proven safe and that they will seek regulatory approvals for inoculations in China.
(FILES) In this file photo taken on December 9, 2020, a health worker prepares a syringe to inoculate a volunteer with a COVID-19 vaccine produced by China’s Sinopharm during its trial at the Clinical Studies Center of the Cayetano Heredia University in Lima. – Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said on December 30, 2020, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia. (Photo by ERNESTO BENAVIDES / AFP)
Phase 3 trials of a Sinopharm coronavirus vaccine found it was 79 percent effective, the Chinese pharma giant said Wednesday, lower than rival jabs developed by Pfizer-BioNTech and Moderna but a potential breakthrough in the battle to stem the pandemic in Asia.
Sinopharm vaccine 79% effective against Covid-19 – but what does this mean?
Vaccine was approved for use in the UAE this month after trials indicated it was 86 per cent effective
Dr Nawal Al Kaabi, chair of the National Covid-19 Clinical Management Committee and Dr Walid Zaher, vaccine project leader at G42 Healthcare, pictured in Abu Dhabi. Their teams will lead a plan to produce the Sinopharm vaccine in the UAE this year. Victor Besa / The National
Dr Al Kaabi, pictured with Ashish Koshy, chief executive of Sinopharm vaccine trial partner G42 Healthcare, said the country aims to inoculate 70 per cent of the population to achieve herd immunity. Victor Besa / The National
The Latest: Britain OKs vaccine by Oxford-AstraZeneca myjournalcourier.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from myjournalcourier.com Daily Mail and Mail on Sunday newspapers.
Victoria will shut its border to NSW at 11.59pm on January 1.
The state has reported another two new cases linked to a person from NSW, making it five new cases today.
Acting Victorian Premier Jacinta Allan says it was not an easy decision to make. This has been a difficult year, with many difficult decisions to make, she says. We have to do everything we possibly can to lock in the situation we have here in Victoria.
11.09PM – Dec 31, 2020
Thank you for reading.
Here s what we learnt today:
It will be a quiet New Year s Eve across the country for many residents with state governments restricting celebrations. Melbourne s fireworks are cancelled and Sydney has banned crowds from watching the firework displays.